Table 1 Comparison of clinicopathological factors between patients with PLNR < 0.1 and PLNR ≥ 0.1
PLNR < 0.1 | PLNR ≥ 0.1 | Univariate | ||||
|---|---|---|---|---|---|---|
n = 75 | n = 42 | P-value | ||||
Age (years) | < 70 | 42 | (56%) | 26 | (62%) | 0.564 |
≥ 70 | 33 | (44%) | 16 | (38%) | ||
Sex | Female | 15 | (20%) | 5 | (12%) | 0.315 |
Male | 60 | (80%) | 37 | (88%) | ||
Histological type | Differentiated | 49 | (65%) | 24 | (57%) | 0.429 |
Undifferentiated | 26 | (35%) | 18 | (43%) | ||
Venous invasion | Negative | 43 | (57%) | 2 | (5%) | < 0.001 |
Positive | 32 | (43%) | 40 | (95%) | ||
Lymphatic invasion | Negative | 43 | (57%) | 8 | (19%) | < 0.001 |
Positive | 32 | (43%) | 34 | (81%) | ||
Tumour size (mm) | < 40 | 38 | (51%) | 6 | (14%) | < 0.001 |
≥ 40 | 37 | (49%) | 36 | (86%) | ||
Neoadjuvant chemotherapy | Absence | 71 | (95%) | 34 | (81%) | 0.027 |
Presence | 4 | (5%) | 8 | (19%) | ||
Pathological T status | T1 | 36 | (48%) | 0 | (0%) | < 0.001 |
T2 | 11 | (15%) | 5 | (12%) | ||
T3 | 21 | (28%) | 19 | (45%) | ||
T4 | 7 | (9%) | 18 | (43%) | ||
Pathological N status | N0 | 56 | (75%) | 0 | (0%) | < 0.001 |
N1 | 12 | (16%) | 1 | (2%) | ||
N2 | 6 | (8%) | 15 | (36%) | ||
N3 | 1 | (1%) | 26 | (62%) | ||
TNM pStage | I | 37 | (49%) | 0 | (0%) | < 0.001 |
II | 19 | (25%) | 0 | (0%) | ||
III | 17 | (23%) | 11 | (26%) | ||
IV | 2 | (3%) | 31 | (74%) | ||